Board Meeting3 Aug 2026, 05:31 pm
Amerise Biosciences Ltd Board Approves Un-audited Financial Results
AI Summary
Amerise Biosciences Ltd announced that its Board of Directors, in a meeting held on August 3, 2026, considered and approved the un-audited standalone financial results for the quarter ended June 30, 2026. The meeting commenced at 04:50 PM and concluded at 05:10 PM. The financial results have been reviewed by the Audit Committee and approved by the Board. The Statutory Auditors have also carried out a limited review. The company operates in a single segment.
Key Highlights
- Board meeting held on August 3, 2026.
- Approved un-audited standalone financial results.
- Results are for the quarter ended June 30, 2026.
- Audit Committee and Statutory Auditors reviewed the results.
- Company has a single business segment.
Price Impact
More from AMERISE